Coracten is often a dihydropyridine calcium-channel blocker which is contraindicated in patients with regarded significant dihydropyridine hypersensitivity.Nifedipine can be used in combination with beta-blocking medicines and also other antihypertensive brokers, but the potential of an additive outcome resulting in postural hypotension really shou